Pain localized to the metatarsal head region of the right foot, classified under enthesopathies and other soft tissue disorders of the foot.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 7
- Region
- Foot & ankle
Documentation tips
What should appear in the chart to support M77.41.
Source · Editorial brief grounded in 5 cited references ↓
- Explicitly state 'right foot' in the assessment — vague documentation such as 'bilateral foot pain' will push the coder to M77.40 (unspecified), losing laterality specificity.
- Record the location of pain as under the metatarsal heads, along with aggravating factors (weight-bearing, footwear) and findings from physical exam such as a positive metatarsal squeeze test.
- If imaging was obtained, note any relevant findings — plantar fat pad atrophy, stress reaction, or metatarsophalangeal joint changes — that support the clinical diagnosis.
- Document any prior conservative management (orthotics, shoe modification, physical therapy, NSAIDs) to support medical necessity for injections or surgical referral.
- If a comorbid structural deformity (e.g., hammertoe, hallux valgus) is present in the right foot, document it separately — it may warrant its own code and influence the treatment plan.
Related CPT procedures
Procedure codes commonly billed with M77.41. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M77.41 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M77.40 (unspecified foot) when laterality is clearly documented in the note — always code to the highest specificity supported by the record.
- Using M77.41 as the principal diagnosis when a documented underlying etiology such as Morton's neuroma (G57.61) or hallux valgus (M20.11) is the actual focus of treatment — sequence the causative condition first.
- Assigning M77.41 for diffuse forefoot pain without metatarsal head localization; diffuse or unlocalized foot pain codes more accurately to M79.671 (pain in right foot).
- Failing to append both M77.41 and M77.42 when bilateral metatarsalgia is documented — there is no single bilateral code in this subcategory.
- Billing CPT 20550 or 20551 with an injection site that doesn't match the documented diagnosis laterality, triggering a 'procedure not compatible with diagnosis' denial.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M77.41 captures metatarsalgia confirmed in the right foot — pain concentrated under the metatarsal heads, typically aggravated by weight-bearing, prolonged standing, or tight footwear. It sits under the M77.4 parent (Metatarsalgia) with three laterality options: M77.40 (unspecified foot), M77.41 (right foot), and M77.42 (left foot). Use M77.41 only when the provider has explicitly documented right-foot involvement. If both feet are affected, assign M77.41 and M77.42 together — there is no bilateral combination code in this subcategory.
M77.41 groups into MS-DRG 557 (Tendonitis, myositis and bursitis with MCC) or 558 (without MCC). It is a recognized covered diagnosis under CMS LCD A57079 for tendon/ligament/Morton's neuroma injections, making it a supported code when billing CPT 20550 or 20551 for metatarsal head corticosteroid injections. Confirm the clinical note supports the injection site aligns with the metatarsal heads of the right foot — payer denial risk increases when the procedure site and diagnosis laterality conflict.
Metatarsalgia is a symptom-level diagnosis. When an underlying cause is identified — such as Morton's neuroma (G57.61), hallux valgus deformity (M20.11), or a stress fracture (M84.371-) — code the underlying condition as principal when it's the focus of care. M77.41 may be retained as an additional code to describe the pain pattern if it adds clinical specificity not captured by the primary diagnosis.
Sibling codes
Other billable codes under M77.4 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the difference between M77.41 and M77.40?
02Is there a bilateral metatarsalgia code?
03Can M77.41 support billing for a metatarsal head injection (CPT 20550)?
04Should M77.41 be used when Morton's neuroma is documented?
05Does M77.41 require a 7th character extension?
06What MS-DRGs does M77.41 map to?
07When should M77.41 be the principal diagnosis versus a secondary code?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective October 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M70-M79/M77-/M77.41
- 03cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=57079&ver=7
- 04vsac.nlm.nih.govhttps://vsac.nlm.nih.gov/context/cs/codesystem/ICD10CM/version/2023/code/M77.41/info
- 05icdcodes.aihttps://icdcodes.ai/diagnosis/metatarsalgia/documentation
Mira AI Scribe
Mira captures right-foot laterality, metatarsal head pain location, aggravating factors (weight-bearing, footwear), metatarsal squeeze test result, and any imaging findings from the encounter note. This prevents coder fallback to M77.40 (unspecified foot), which can trigger payer queries and strip laterality from the claim — particularly relevant when pairing M77.41 with injection CPT codes covered under CMS A57079.
See how Mira captures M77.41 documentation